Jones Financial Companies’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.8K | Buy |
724
+88
| +14% | +$462 | ﹤0.01% | 3234 |
|
2025
Q1 | $5.65K | Sell |
636
-954
| -60% | -$8.47K | ﹤0.01% | 2918 |
|
2024
Q4 | $21.8K | Buy |
1,590
+36
| +2% | +$494 | ﹤0.01% | 2221 |
|
2024
Q3 | $41.1K | Buy |
1,554
+394
| +34% | +$10.4K | ﹤0.01% | 1712 |
|
2024
Q2 | $28.4K | Buy |
+1,160
| New | +$28.4K | ﹤0.01% | 1434 |
|
2024
Q1 | – | Sell |
-106
| Closed | -$2.03K | – | 1418 |
|
2023
Q4 | $2.03K | Buy |
106
+65
| +159% | +$1.24K | ﹤0.01% | 906 |
|
2023
Q3 | $658 | Buy |
+41
| New | +$658 | ﹤0.01% | 658 |
|
2021
Q4 | – | Sell |
-60
| Closed | -$2K | – | 767 |
|
2021
Q3 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 622 |
|